Literature DB >> 28636993

Polymorphisms and expression pattern of circular RNA circ-ITCH contributes to the carcinogenesis of hepatocellular carcinoma.

Wenzhi Guo1, Jiakai Zhang1, Dongyu Zhang2, Shengli Cao1, Gongquan Li1, Shuijun Zhang1, Zhihui Wang1, Peihao Wen1, Han Yang1, Xiaoyi Shi1, Jie Pan1, Hua Ye3.   

Abstract

Hepatocellular carcinoma (HCC) ranks the sixth most common cancer and the third cause of cancer-related mortality worldwide. Recent studies identified that circ-ITCH Suppresses mutiple cancers proliferation via inhibiting the Wnt/beta-Catenin pathway. In current study, conducted a genetic association study together with epidemiological follow-up study to delineate the role of circ-ITCH in the development and progression of HCC. we found rs10485505 (adjusted OR =1.18; 95% CI=1.06-1.31; P value =3.1×10-3) and rs4911154 (adjusted OR =1.27; 95% CI=1.14-1.43; P value =3.7×10-5) were significantly associated with increased HCC risk. The expression level of circ-ITCH was significantly lower in HCC tissues, compared with that in adjacent tissues (P value < 0.001). Cox regression analysis indicated that high expression of circ-ITCH was associated with favorable survival of HCC (HR=0.45; 95% CI=0.29-0.68; P value < 0.001). These results indicate that circ-ITCH may have an inhibitory effect on HCC, and could serve as susceptibility and prognostic biomarkers for HCC patients.

Entities:  

Keywords:  circ-ITCH; hepatocellular carcinoma; survival; susceptibility

Mesh:

Substances:

Year:  2017        PMID: 28636993      PMCID: PMC5564635          DOI: 10.18632/oncotarget.18327

Source DB:  PubMed          Journal:  Oncotarget        ISSN: 1949-2553


INTRODUCTION

Hepatocellular carcinoma (HCC) ranks the sixth most common cancer and the third cause of cancer-related mortality worldwide [1, 2]. In Asia and sub-Saharan Africa areas, over 5% of the populations suffered chronically infected chronic hepatitis B virus (HBV) infection, which could reflect the elevated prevalence of HCC [1, 3–5]. In china, the estimated new cases and deaths for HCC were 466.1 and 422.1 thousands, respectively [6]. While the data for the estimated new cases and deaths for HCC in USA was 39,230 and 27,170, respectively [7]. Although many potential risk factors have been explored for their associations with susceptibility of HCC, the etiological factors and pathogenesis mechanisms underlying HCC development appear to be complex and heterogeneous [3, 8–13]. Circular RNAs (circRNAs) are an enigmatic class of RNA with unknown function [14]. With the development of next-generation sequencing (NGS), especially RNA sequencing technology, over 30,000 circRNAs have already been detected [15]. Emerging studies indicates that circRNAs, serving as potential diagnostic and predictive biomarkers, play important roles in the development and progression of multiple cancers [16-21]. It's reported that circRNAs play a vital role in many aspects of malignant phenotypes, including cell cycle, apoptosis, vascularization, and invasion, and metastasis [15, 22, 23]. Further exploration of the functions of circRNAs as molecular markers in carcinogenesis of cancer will provide potential application perspectives, such as early tumor diagnosis, therapeutic target screening, prognosis prediction, and target-therapy for tumors. Recently, Li et al [24] found that circ-ITCH had inhibitory effect on esophageal squamous cell carcinoma (ESCC) by suppressing the Wnt/β-catenin pathway. Furthermore, Wan et al [25] replicated the similar mechanism in lung cancer. However, there are no reported studies on the functional roles of circ-ITCH in HCC. In this study, we hypothesized that circ-ITCH might be involved in the carcinogenesis of HCC. SNPs in the circ-ITCH gene region may conclusively affect individual variation in inhibitory effect of circ-ITCH, and modulate individual cancer susceptibility. So investigation of SNPs in circ-ITCH gene contributes to uncovering pathogenesis of HCC. To address this hypothesis, we conducted this genetic association study together with epidemiological follow-up study to delineate the role of circ-ITCH in the development and progression of HCC.

RESULTS

Characteristics of study subjects

A totally of 1,600 HCC cases and 1,800 cancer-free controls were recruited for the genetic association study. Table 1 presents the basic characteristics of the studied population. The distributions of most variables, including age, gender, HBV infection status, smoking status, and education level, were comparable between the HCC cases and cancer-free controls (P value > 0.05). However, a significant difference for the distributions of alcohol status and family history of cancer were detected (P value < 0.001).
Table 1

Demographic and epidemiological characteristics of the study population

VariablesHCC (N=1800)Controls (N=1800)P value
N%N%
Gerder
 Male117065.0121567.50.113
 Female63035.058532.5
Age
 ≥55110261.2108960.50.657
 <5569838.871139.5
HBV infection
 HBsAg +45025.041423.00.160
 HBsAg -135075.0138677.0
Smoking status
 Ever36920.536020.00.709
 Never143179.5144080.0
Alcohol status
 Ever54030.039622.0P<0.001
 Never126070.0140478.0
Family history of cancer
 Yes995.5181.0P<0.001
 No170194.5178299.0
Education level
 <College degree145881.0143179.50.258
 ≥College degree34219.036920.5

Association analysis between the tagSNPs in circ-ITCH and HCC risk

Figure 1 presents the linkage disequilibrium (LD) information of the SNPs located in the gene region of circ-ITCH, during which six SNPs with minor allele frequency (MAF) ≥0.05 in Chinese Han population were selected as tagSNPs. As shown in Table 2, we present the genotype distribution of the selected SNPs and their associations with HCC risk. The genotype frequencies of all six SNPs among both cases and controls were consistent with Hardy-Weinberg equilibrium (HWE) (P value > 0.05). Results of additive model indicated that the genotype distribution of rs10485505 (adjusted OR =1.18; 95% CI=1.06-1.31; P value =3.1×10-3) and rs4911154 (adjusted OR =1.27; 95% CI=1.14-1.43; P value =3.7×10-5) were significantly associated with HCC risk. For rs10485505, compared with the genotype CC, genotype CT (adjusted OR =1.18; 95% CI=1.03-1.35) and TT (adjusted OR =1.40; 95% CI= 1.04-1.88) were significantly associated with increased HCC risk; while for rs4911154, compared with the genotype GG, genotype GA (adjusted OR =1.27; 95% CI= 1.10-1.46) and AA (adjusted OR =1.74; 95% CI= 1.21-2.49) were significantly associated with increased HCC risk.
Figure 1

TagSNP selection of circ-ITCH

SNPinfo Web Server (https://snpinfo.niehs.nih.gov/) was used for the tagSNP selection of circ-ITCH.

Table 2

Circ-ITCH genotypes and the risk of HCC

Cases (N=1800)Controls (N=1800)OR (95% CIs) *P trend
rs6059851
 GG640 (35.6%)600 (33.3%)1.00 (reference)
 GA878 (48.8%)870 (48.3%)1.04 (0.90-1.20)
 AA342 (19.0%)330 (18.4%)1.07 (0.89-1.29)
 A vs G1.04 (0.94-1.24)0.452
rs6120663
 CC1027 (57.1%)1035 (57.5%)1.00 (reference)
 AC685 (38.1%)673 (37.4%)1.02 (0.89-1.18)
 AA88 (4.9%)92 (5.1%)0.96 (0.71-1.31)
 A vs C1.01 (0.90-1.12)0.912
rs10485505
 CC1001 (55.6%)1083 (60.2%)1.00 (reference)
 CT689 (38.3%)632 (35.1%)1.18 (1.03-1.35)
 TT110 (6.1%)85 (4.7%)1.40 (1.04-1.88)
 T vs C1.18 (1.06-1.31)3.1×10-3
rs4911154
 GG1089 (60.5%)1200 (66.7%)1.00 (reference)
 GA632 (35.1%)550 (30.5%)1.27 (1.10-1.46)
 AA79 (4.4%)50 (2.8%)1.74 (1.21-2.49)
 A vs G1.27 (1.14-1.43)3.7×10-5
rs7266300
 AA1053 (58.5%)1002 (55.7%)1.00 (reference)
 AT665 (36.9%)699 (38.8%)0.90 (0.79-1.04)
 TT82 (4.6%)99 (5.5%)0.79 (0.58-1.07)
 T vs A0.90 (0.81-1.00)0.061
rs11167234
 TT819 (45.5%)820 (45.6%)1.00 (reference)
 TA783 (43.5%)775 (43.0%)1.01 (0.88-1.16)
 AA198 (11.0%)205 (11.4%)0.97 (0.78-1.20)
 A vs T0.99 (0.90-1.09)0.880

* Adjusted for age, gender, HBV infection, family history of cancer, smoking status, alcohol status, and education level.

TagSNP selection of circ-ITCH

SNPinfo Web Server (https://snpinfo.niehs.nih.gov/) was used for the tagSNP selection of circ-ITCH. * Adjusted for age, gender, HBV infection, family history of cancer, smoking status, alcohol status, and education level.

Expression of circ-ITCH in HCC and the adjacent tissues

To explore the influence of expression of circ-ITCH on occurrence of HCC, a TaqMan-based qRT-PCR assay was used for the divergent primer set to determine the levels of ITCH in 288 HCC samples and matched adjacent tissues. As shown in Figure 2, the expression level of circ-ITCH was significantly lower in HCC tissues, compared with that in adjacent tissues (P value < 0.001).
Figure 2

Comparison of circ-ITCH expression levels between HCC tissues and adjacent tissues

Mann–Whitney U-test was used to analyze the expression difference of circ-ITCH between HCC tissues and adjacent non-cancerous tissues.

Comparison of circ-ITCH expression levels between HCC tissues and adjacent tissues

Mann–Whitney U-test was used to analyze the expression difference of circ-ITCH between HCC tissues and adjacent non-cancerous tissues.

Survival analysis of circ-ITCH in HCC

Furthermore, to determine whether circ-ITCH could serve as prognostic marker for HCC, we analyzed the association between expression of circ-ITCH and prognosis of HCC in the 288 HCC cases with follow-up data. As shown in Figure 3, the difference between the survival curves of the two groups was statistically significant (P value < 0.001). Cox regression analysis indicated that high expression of circ-ITCH was associated with favorable survival of HCC (HR=0.45; 95% CI=0.29-0.68; P value < 0.001). This indicated that circ-ITCH could work as an prognostic indicator for HCC.
Figure 3

Prognostic value of circ-ITCH

Kaplan–Meier curves were utilized to assess the association between the circ-ITCH and overall survival of HCC patients.

Prognostic value of circ-ITCH

Kaplan–Meier curves were utilized to assess the association between the circ-ITCH and overall survival of HCC patients.

DISCUSSION

In this study, we have used a candidate gene approach to examine the associations between genetic variations of circ-ITCH and susceptibility of HCC. We also evaluated the possibility of the expression of circ-ITCH as an susceptibility and prognostic biomarker for HCC. To the best of our knowledge, This should be the first study which aims to investigate the role of circ-ITCH in the development and progression of HCC. Our findings demonstrated that rs10485505 and rs4911154 were significantly associated with increased risk of HCC, and the expression of circ-ITCH could serve as susceptibility and prognostic biomarkers for HCC patients. CircRNAs are a novel type of RNAs, which are generated primarily through a type of alternative RNA splicing called “back-splicing,” a downstream splice donor being joined to an upstream splice acceptor through splice skipping or direct splice [16]. They could be used as molecular markers or potential targets for early tumor diagnosis, therapeutic evaluation, prognosis prediction, and even gene therapy for tumors [15]. Li et al [26] found circRNA could be a critical factor in HCC using RNA-seq data of 100 samples consisting of tumor tissues and para-carcinoma tissues from 50 HCC patients were downloaded from the Sequence Reads Archive (SRP068976). Recent studies demonstrated that circ-ITCH Suppresses mutiple cancers proliferation via inhibiting the Wnt/beta-Catenin pathway [24, 25, 27]. Wnt/beta-Catenin pathway, which regulates some of the crucial aspects of cellular processes, plays important role in the carcinogenesis progress of many cancers [28-38]. ITCH could hyper expression promotes ubiquitination and degradation of phosphorylated Dvl2, thereby inhibiting the Wnt/β-catenin pathway [24]. Song et al [37] reported that Wnt/beta-catenin was also an oncogenic pathway targeted by H. pylori in gastric carcinogenesis. Genetic polymorphisms of Wnt/beta-catenin pathway genes are also associated with the susceptibility, survival, efficacy and toxicities of radiotherapy of multiple cancers [39-45]. In current study, we found the expression level of circ-ITCH in HCC tissues was significantly lower than the level in adjacent tissues, which indicated that circ-ITCH worked as an tumor suppressor gene for carcinogenesis of HCC, consistent with its function in ESCC, colorectal cancer, and lung cancer. Circ-ITCH was located on chromosome 20q11.22, and spans exons 6–13 of gene ITCH, which encodes a member of the Nedd4 family of HECT domain E3 ubiquitin ligases [46]. Mutations in this gene are a cause of syndromic multisystem autoimmune disease [47, 48]. In the genetic association study, we first found that rs10485505 and rs4911154 in circ-ITCH were significantly associated with increased risk of HCC with a relatively large sample size in a well-established population. Using RegulomeDB [49], the score for rs10485505 and rs4911154 were both ‘1f’, which means Likely to affect binding and linked to expression of a gene target. These data open new perspectives on a possible genetic determinants of HCC in candidate CircRNAs. Our study has several strengths. First, the large sample size provides enough statistical power to detect such moderate associations. Second, we have included the genetic-homogenous participants, which were all Han Chinese population. Although our study revealed some interesting findings, there still exist some limitations. One limitation was that the findings were not validated in an independent cohort. Secondly, further mechanism of circ-ITCH and its SNP affecting susceptibility and prognosis of HCC was not explored here [50]. However, these new findings still provide a detailed genomic landscape in which to examine biological mechanisms of HCC. In summary, our study showed that the expression level of circ-ITCH in HCC tissues was significantly lower than the level in adjacent tissues, and high expression of circ-ITCH was associated with favorable survival of HCC. We also found that rs10485505 and rs4911154 in circ-ITCH were significantly associated with increased risk of HCC. This study indicates that circ-ITCH not only has prognostic significance, but also susceptibility biomarker for HCC. Meanwhile, genetic variation of circ-ITCH can also be used as the biomarkers for prediction and screening of HCC. These findings should be verified by larger, well-designed epidemiologic and functional studies.

MATERIALS AND METHODS

Subjects

Totally included in current study were 1,600 HCC cases and 1,800 cancer-free controls. All cases were pathologically confirmed as HCC, and all subjects in this study were homogenous Han Chinese. The control subjects were randomly enrolled at the same period when they visit the hospital for physical examinations, matched by age, gender, HBV infection status, and education level. Demographic data and environmental exposure history of each participants were collected by face to face interviews. Blood (10ml) was collected for each patient. Plasma was separated immediately and stored at -80°C before use, while tissue samples were snap-frozen in liquid nitrogen immediately after dissection and then stored at −80°C before RNA extraction. The study was approved by the institutional review board of the hospital, and a written informed consent was collected from all individual participants of the study.

RNA extraction and real-time quantitative polymerase chain reaction

Total RNA was extracted from 288 randomly selected HCC tissue samples and matched adjacent tissues using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol. The quality of the RNA samples were measured using Agilent 2100 bioanalyzer, and an Integrity Number value above 6.0 indicated acceptable RNA integrity for RT-PCR assays. The relative gene expression of circ-ITCH (primers: the forward GCAGAGGCCAACACTGGAA, the reverse TCCTTGAAGCTGACTACGCTGAG) was determined using the ABI Prism 7900 sequence detection system (Applied Biosystems, Foster City, CA, USA), and GAPDH was used as an internal standard control. All reactions were performed in triplicate.

SNP selection and genotyping

SNPinfo Web Server (https://snpinfo.niehs.nih.gov/) was used for the tagSNP selection of circ-ITCH. As shown in Figure 1, Six SNPs with minor allele frequency (MAF) ≥0.05 in Chinese Han population, including rs6059851, rs6120663, rs10485505, rs4911154, rs7266300, rs11167234, were selected for this study. Genomic DNA was extracted from peripheral blood of each study subject. TaqMan allelic discrimination assay was used to genotype the selected SNPs by using the ABI 7900HT Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). For quality control, we randomly selected 10% of the samples for repeated genotyping, and the results were 100% concordant.

Statistical analyses

Student's t test and Pearson's chi-squared (χ2) test were used to assess the differences in demographic factors between HCC cases and controls. Hardy-Weinberg equilibrium (HWE) of the controls was done by a goodness-of-fit χ2 test. The ORs and 95% CIs were calculated by an unconditional logistic regression model for the associations between genotype distribution and HCC susceptibility. Mann–Whitney U-test was used to analyze the expression difference of circ-ITCH between HCC tissues and adjacent non-cancerous tissues. Patients were divided into low or high expression groups of circ-ITCH according to the median value. Kaplan–Meier and Cox regression analyses were utilized to assess the association between the circ-ITCH and overall survival of HCC patients. Statistical analyses were performed by using SPSS software package (Version 13.0, SPSS Inc., Chicago, IL, USA), and all reported p values were two-sided with a significance level of 0.05.
  49 in total

1.  The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice.

Authors:  W L Perry; C M Hustad; D A Swing; T N O'Sullivan; N A Jenkins; N G Copeland
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

2.  Circular RNA: a novel biomarker for progressive laryngeal cancer.

Authors:  Lijia Xuan; Lingmei Qu; Han Zhou; Peng Wang; Haoyang Yu; Tianyi Wu; Xin Wang; Qiuying Li; Linli Tian; Ming Liu; Yanan Sun
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

3.  A sequence polymorphism in miR-608 predicts recurrence after radiotherapy for nasopharyngeal carcinoma.

Authors:  Jian Zheng; Jieqiong Deng; Mang Xiao; Lei Yang; Liyuan Zhang; Yonghe You; Min Hu; Na Li; Hongchun Wu; Wei Li; Jiachun Lu; Yifeng Zhou
Journal:  Cancer Res       Date:  2013-06-24       Impact factor: 12.701

4.  The role of Wnt/β-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: evidences from patients-derived cell lines.

Authors:  Daniela Kovacs; Emilia Migliano; Luca Muscardin; Vitaliano Silipo; Caterina Catricalà; Mauro Picardo; Barbara Bellei
Journal:  Oncotarget       Date:  2016-07-12

5.  Circular RNA-ITCH Suppresses Lung Cancer Proliferation via Inhibiting the Wnt/β-Catenin Pathway.

Authors:  Li Wan; Lin Zhang; Kai Fan; Zai-Xing Cheng; Quan-Chao Sun; Jian-Jun Wang
Journal:  Biomed Res Int       Date:  2016-08-24       Impact factor: 3.411

6.  In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.

Authors:  Ling-Yu Kong; Mei Xue; Qing-Cai Zhang; Chuan-Fu Su
Journal:  Oncotarget       Date:  2017-02-28

7.  Association of single nucleotide polymorphisms in Wnt signaling pathway genes with breast cancer in Saudi patients.

Authors:  Mohammad Saud Alanazi; Narasimha Reddy Parine; Jilani Purusottapatnam Shaik; Huda A Alabdulkarim; Sana Abdulla Ajaj; Zahid Khan
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

Review 8.  Wnt/β-catenin, an oncogenic pathway targeted by H. pylori in gastric carcinogenesis.

Authors:  Xiaowen Song; Na Xin; Wei Wang; Chenghai Zhao
Journal:  Oncotarget       Date:  2015-11-03

9.  Silencing of cZNF292 circular RNA suppresses human glioma tube formation via the Wnt/β-catenin signaling pathway.

Authors:  Ping Yang; Zhijun Qiu; Yuan Jiang; Lei Dong; Wensheng Yang; Chao Gu; Guang Li; Yu Zhu
Journal:  Oncotarget       Date:  2016-09-27

10.  PDIA6 promotes the proliferation of HeLa cells through activating the Wnt/β-catenin signaling pathway.

Authors:  Huijun Gao; Bing Sun; Hailu Fu; Xinming Chi; Faming Wang; Xiaoyu Qi; Jun Hu; Shujuan Shao
Journal:  Oncotarget       Date:  2016-08-16
View more
  53 in total

1.  A novel circular RNA hsa_circ_0020123 exerts oncogenic properties through suppression of miR-144 in non-small cell lung cancer.

Authors:  Danhua Qu; Bingdi Yan; Rui Xin; Tiangang Ma
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

Review 2.  A 360° view of circular RNAs: From biogenesis to functions.

Authors:  Jeremy E Wilusz
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-14       Impact factor: 9.957

Review 3.  Circular RNAs in digestive system cancer: potential biomarkers and therapeutic targets.

Authors:  Jia-Qi Sheng; Lian Liu; Mu-Ru Wang; Pei-Yuan Li
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

Review 4.  The roles of E3 ligases in Hepatocellular carcinoma.

Authors:  Zongdong Yu; Hong Li; Jie Zhu; Haibiao Wang; Xiaofeng Jin
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

Review 5.  circRNAs in Cancer.

Authors:  Ines Lucia Patop; Sebastian Kadener
Journal:  Curr Opin Genet Dev       Date:  2017-12-12       Impact factor: 5.578

6.  Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis.

Authors:  LiLi Zhao; Ning Ma; Gaihong Liu; Ni Mao; Fei Chen; Jiao Li
Journal:  Dig Dis Sci       Date:  2021-01-12       Impact factor: 3.199

7.  Circular RNA CircITCH (has-circ-0001141) suppresses hepatocellular carcinoma (HCC) progression by sponging miR-184.

Authors:  Xuan Guo; Ziying Wang; Xue Deng; Yantong Lu; Xuhui Huang; Juze Lin; Xiaohe Lan; Qiao Su; Changjun Wang
Journal:  Cell Cycle       Date:  2022-04-09       Impact factor: 5.173

Review 8.  Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma.

Authors:  Rui Liao; Lei Liu; Jian Zhou; Xufu Wei; Ping Huang
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

9.  Identification and integrated analysis of differentially expressed lncRNAs and circRNAs reveal the potential ceRNA networks during PDLSC osteogenic differentiation.

Authors:  Xiuge Gu; Mengying Li; Ye Jin; Dongxu Liu; Fulan Wei
Journal:  BMC Genet       Date:  2017-12-02       Impact factor: 2.797

Review 10.  Circular RNAs in cancer: opportunities and challenges in the field.

Authors:  L S Kristensen; T B Hansen; M T Venø; J Kjems
Journal:  Oncogene       Date:  2017-10-09       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.